Mankind Pharma Limited
Mankind Pharma Limited scores highest on Nitro (66) and lowest on Price (37). Its PosiPenta is 52.18 out of 100, around the middle of similar companies.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Details
PPrice
| P/E ratio | 44.77 |
| P/B ratio | 5.61 |
EEarnings
| Trailing EPS | ₹49.42 |
| Forward EPS | ₹70.81 |
NNitro
| Price | 2212.60 |
| 52-week high | 2642.00 |
| 52-week low | 1909.70 |
| Fall from 52-week high | 16.3% |
TTorque
| Return on equity (ROE) (calculated) | 12.52% |
| Debt-to-equity | 0.38 |
AAnchor
| Beta (price swings) | 0.45 |
| Market cap | ₹91,390 Cr |
| Promoter holding | 72.62% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Mankind Pharma Limited's PosiPenta score?
Mankind Pharma Limited's PosiPenta is 52.18 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Which PosiPenta pillar is strongest for Mankind Pharma Limited?
Nitro (momentum), with a score of 66 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Mankind Pharma Limited?
Price (valuation), with a score of 37 out of 100: weaker than most similar companies.
Has Mankind Pharma Limited's PosiPenta changed since last week?
Yes, it fell 0.36 points, from 52.54 to 52.18.
PositoAI is for research and education only and is not investment advice.